Post by Secarna Pharmaceuticals

We warmly welcome Jens Holstein and Richard Engelhard to Secarna Pharmaceuticals newly established Advisory Board!   As seasoned financial and industry experts, their valuable insights will guide us on our mission to transform untreatable medical conditions into treatable ones as we strive to bring our lead compounds SECN-15 and SECN-69 to clinical proof of concept.   Find out more details in our press release https://lnkd.in/dsVzjGBH